2025. Adherence and identification of access barriers in patients with autoimmune diseases treated with an adalimumab biosimilar in Colombia. Universitas Scientiarum. (Oct. 2025), S17. DOI:https://doi.org/10.11144/Javeriana.SCSI30.aaio.